State of the art: Evaluation and prognostication of myocarditis using cardiac MRI

Journal of Magnetic Resonance Imaging

Volumn 49, Issue 7, 2019, Pages e122-e131

  Gannon, Michael P ^a   Schaub, Ebe ^b   Grines, Cindy L ^c   Saba, Shahryar G ^c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

cardiovascular magnetic resonance imaging; Lake Louise Criteria; myocarditis; parametric mapping; T1 mapping

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAPHY; GIANT CELL MYOCARDITIS; HEART INFARCTION; HEART MUSCLE BIOPSY; HUMAN; INCIDENCE; LAKE LOUISE CRITERIA; MYOCARDIAL INFARCTION WITH NONOBSTRUCTIVE CORONARY ARTERY; MYOCARDITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RADIOLOGICAL PARAMETERS; REVIEW; VIRUS MYOCARDITIS; ADULT; BIOPSY; CARDIAC MUSCLE; CLINICAL DECISION SUPPORT SYSTEM; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC IMAGING; FEMALE; HEART; INFLAMMATION; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; YOUNG ADULT;

ADULT; BIOPSY; CARDIOMYOPATHY, DILATED; DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; HEART; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; PROGNOSIS; YOUNG ADULT;

EID: 85060010442     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.26611     Document Type: Review

References (60)

1. Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald's heart disease: A textbook of cardiovascular medicine, 10th ed. Philadelphia: Elsevier/Saunders; 2015.
2. Gupta S, Markham DW, Drazner MH, Mammen PP. Fulminant myocarditis. Nat Clin Pract Cardiovasc Med 2008;5:693–706.
3. McCarthy RE, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690–695.
4. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269–275.
5. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm 2005;2:1277–1282.
6. Fontaine G, Fornes P, Fontaliran F. Myocarditis as a cause of sudden death. Circulation 2001;103:e12; author reply e12.
7. Babu-Narayan SV, McCarthy KP, Ho SY, Magee AG, Kilner PJ, Sheppard MN. Images in cardiovascular medicine. Myocarditis and sudden cardiac death in the young: Extensive fibrosis suggested by cardiovascular magnetic resonance in vivo and confirmed post mortem. Circulation 2007;116:e122–125.
8. Karjalainen J, Heikkilä J. Incidence of three presentations of acute myocarditis in young men in military service. A 20-year experience. Eur Heart J 1999;20:1120–1125.
9. Cooper LT Jr, Keren A, Sliwa K, Matsumori A, Mensah GA. The global burden of myocarditis. Global Heart 2014;9:121–129.
10. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077–1084.
11. Nordenskjöld AM, Baron T, Eggers KM, Jernberg T, Lindahl B. Predictors of adverse outcome in patients with myocardial infarction with non-obstructive coronary artery (MINOCA) disease. Int J Cardiol 2018;261:18–23.
12. Patriki D, Gresser E, Manka R, Emmert MY, Lüscher TF, Heidecker B. Approximation of the incidence of myocarditis by systematic screening with cardiac magnetic resonance imaging. JACC Heart Fail 2018 [Epub ahead of print].
13. Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636–2648; 2648a–2648d.
14. Frustaci A, Cuoco L, Chimenti C, et al. Celiac disease associated with autoimmune myocarditis. Circulation 2002;105:2611–2618.
15. Noutsias M, Tschope C. Giant cell myocarditis: Still a conundrum. The need for a worldwide registry. Eur J Heart Fail 2016;18:1459–1461.
16. Cooper LT Jr. Myocarditis. N Engl J Med 2009;360:1526–1538.
17. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001;104:1076–1082.
18. Jeuthe S, Wassilew K, O H-ici D, et al. Myocardial T1 maps reflect histological findings in acute and chronic stages of myocarditis in a rat model. J Cardiovasc Magn Reson 2016;18:19.
19. Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol 2012;59:779–792.
20. Opavsky MA, Penninger J, Aitken K, et al. Susceptibility to myocarditis is dependent on the response of αβ T lymphocytes to coxsackieviral infection. Circ Res 1999;85:551–558.
21. Dennert R, Crijns HJ, Heymans S. Acute viral myocarditis. Eur Heart J 2008;29:2073–2082.
22. Kawai C. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death. Circulation. 1999;99:1091–1100.
23. Gandhi MS, Kamalov G, Shahbaz AU, et al. Cellular and molecular pathways to myocardial necrosis and replacement fibrosis. Heart Fail Rev 2011;16:23–34.
24. Holzmann M, Nicko A, Kuhl U, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: A retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 2008;118:1722–1728.
25. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: Implications for role of sampling error. Mayo Clin Proc 1989;64:1235–1245.
26. Baughman KL. Diagnosis of myocarditis: Death of Dallas criteria. Circulation 2006;113:593–595.
27. Angelini A, Calzolari V, Calabrese F, et al. Myocarditis mimicking acute myocardial infarction: Role of endomyocardial biopsy in the differential diagnosis. Heart 2000;84:245–250.
28. Chopra H, Arangalage D, Bouleti C, et al. Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis. Int J Cardiol 2016;212:63–69.
29. De Lazzari M, Zorzi A, Baritussio A, et al. Relationship between T-wave inversion and transmural myocardial edema as evidenced by cardiac magnetic resonance in patients with clinically suspected acute myocarditis: Clinical and prognostic implications. J Electrocardiol 2016;49:587–595.
30. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009;53:1475–1487.
31. Lee VS. Cardiovascular MRI: Physical principles to practical protocols. Philadelphia: Lippincott Williams & Wilkins; 2006.
32. Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: Part I. J Cardiovasc Magn Reson 2010;12:71.
33. Biglands JD, Radjenovic A, Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: Part II. J Cardiovasc Magn Reson 2012;14:66.
34. Piechnik SK, Ferreira VM, Dall'Armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12:69.
35. Hinojar R, Nagel E, Puntmann VO. T1 mapping in myocarditis—Headway to a new era for cardiovascular magnetic resonance. Expert Rev Cardiovasc Ther 2015;13:871–874.
36. Lurz P, Luecke C, Eitel I, et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: The MyoRacer-Trial. J Am Coll Cardiol 2016;67:1800–1811.
37. Radunski UK, Lund GK, Saring D, et al. T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis. Clin Res Cardiol 2017;106:10–17.
38. Salerno M, Kramer CM. Advances in parametric mapping with CMR imaging. JACC Cardiovasc Imaging 2013;6:806–822.
39. Ferreira VM, Piechnik SK, Dall'Armellina E, et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: Comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 2013;6:1048–1058.
40. Bami K, Haddad T, Dick A, Dennie C, Dwivedi G. Noninvasive imaging in acute myocarditis. Curr Opin Cardiol 2016;31:217–223.
41. Luetkens JA, Doerner J, Thomas DK, et al. Acute myocarditis: Multiparametric cardiac MR imaging. Radiology 2014;273:383–392.
42. Vermes E, Childs H, Carbone I, Barckow P, Friedrich MG. Auto-threshold quantification of late gadolinium enhancement in patients with acute heart disease. J Magn Reson Imaging 2013;37:382–390.
43. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: A comparison to histology and molecular pathology. Circulation 2004;109:1250–1258.
44. Lurz P, Eitel I, Klieme B, et al. The potential additional diagnostic value of assessing for pericardial effusion on cardiac magnetic resonance imaging in patients with suspected myocarditis. Eur Heart J Cardiovasc Imaging 2014;15:643–650.
45. Radunski UK, Lund GK, Stehning C, et al. CMR in patients with severe myocarditis: Diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc Imaging 2014;7:667–675.
46. Ferreira VM, Piechnik SK, Dall'Armellina E, et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson 2014;16:36.
47. Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 2017;19:75.
48. Friedrich MG. Cardiovascular magnetic resonance for myocardial inflammation. Circ Cardiovasc Imaging 2018;11:e008010.
49. Luetkens JA, Homsi R, Sprinkart AM, et al. Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. Eur Heart J Cardiovasc Imaging 2016;17:154–161.
50. Luetkens JA, Homsi R, Dabir D, et al. Comprehensive cardiac magnetic resonance for short-term follow-up in acute myocarditis. J Am Heart Assoc 2016;5.
51. Bohnen S, Radunski UK, Lund GK, et al. Performance of T1 and T2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure clinical perspective. Circ Cardiovasc Imaging 2015;8.
52. Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging 2012;5:513–524.
53. Tornvall P, Brolin EB, Caidahl K, et al. The value of a new cardiac magnetic resonance imaging protocol in Myocardial Infarction with Non-obstructive Coronary Arteries (MINOCA)—A case-control study using historical controls from a previous study with similar inclusion criteria. BMC Cardiovasc Disord 2017;17:199.
54. Pathik B, Raman B, Mohd Amin NH, et al. Troponin-positive chest pain with unobstructed coronary arteries: Incremental diagnostic value of cardiovascular magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 2016;17:1146–1152.
55. Caforio AL, Calabrese F, Angelini A, et al. A prospective study of biopsy-proven myocarditis: Prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 2007;28:1326–1333.
56. Wagner A, Schulz-Menger J, Dietz R, Friedrich MG. Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. MAGMA 2003;16:17–20.
57. Grun S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis: Predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012;59:1604–1615.
58. Kindermann I, Kindermann M, Kandolf R, et al. Predictors of outcome in patients with suspected myocarditis. Circulation 2008;118:639–648.
59. Grani C, Eichhorn C, Biere L, et al. Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis. J Am Coll Cardiol 2017;70:1964–1976.
60. Aquaro GD, Perfetti M, Camastra G, et al. Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY study. J Am Coll Cardiol 2017;70:1977–1987.